Sep 23 2009
Emergent Health Corp. (Other OTC: EMGE) -- Emergent expects to revolutionize the vitamin business. The company plans to introduce an adjuvant formula that enhances existing vitamin products currently on the market to assist in the production of normal cells. With the addition of Emergent's Vita-Stim Adjuvant™, a trademarked and patented formula, existing vitamin companies will be able to deliver scientifically advanced, revolutionary vitamin products and formulas to United States and worldwide customers. Emergent, licensed under a U.S. patent, is positioned well for this innovative approach.
"The multi-vitamin segment of the supplement market is the largest individual segment. An Industry analyst estimates the market for multi-vitamins is $4 Trillion in the USA. Of over 110 top brands only 11 even supplied 25% of what the body is known to need. Our Vita-Stem Adjuvant™ compound stands to revolutionize the whole vitamin industry, as breakthrough adult stem cell based discoveries are further studied and introduced, providing high potency, scientifically researched regenerative properties to existing vitamin brands. It is predicted that today's vitamin products will eventually become obsolete."
Label description is expected "Contains Value Added Vita-Stim Adjuvant™." If merely 50 to 100 mg. of the adjuvant per formula is used, the market implications are obvious.
Integrating traditional medicines with modern nutrition for holistic health